Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4471592
Max Phase: Preclinical
Molecular Formula: C36H58N2O8
Molecular Weight: 646.87
Molecule Type: Unknown
Associated Items:
ID: ALA4471592
Max Phase: Preclinical
Molecular Formula: C36H58N2O8
Molecular Weight: 646.87
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CNCC(=O)N[C@H]1[C@H](O[C@H]2CC[C@@]3(C)C(=CC[C@H]4[C@@H]5C[C@@H]6O[C@]7(CC[C@@H](C)CO7)[C@@H](C)[C@@H]6[C@@]5(C)CC[C@@H]43)C2)O[C@H](CO)[C@@H](O)[C@@H]1O
Standard InChI: InChI=1S/C36H58N2O8/c1-19-8-13-36(43-18-19)20(2)29-26(46-36)15-25-23-7-6-21-14-22(9-11-34(21,3)24(23)10-12-35(25,29)4)44-33-30(38-28(40)16-37-5)32(42)31(41)27(17-39)45-33/h6,19-20,22-27,29-33,37,39,41-42H,7-18H2,1-5H3,(H,38,40)/t19-,20+,22+,23-,24+,25+,26+,27-,29+,30-,31-,32-,33-,34+,35+,36-/m1/s1
Standard InChI Key: OCFHBZGBEGYYKO-KQYKORIISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 646.87 | Molecular Weight (Monoisotopic): 646.4193 | AlogP: 2.88 | #Rotatable Bonds: 6 |
Polar Surface Area: 138.74 | Molecular Species: BASE | HBA: 9 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 12.29 | CX Basic pKa: 8.80 | CX LogP: 2.38 | CX LogD: 0.96 |
Aromatic Rings: 0 | Heavy Atoms: 46 | QED Weighted: 0.28 | Np Likeness Score: 2.64 |
1. Grzywacz D, Paduszyńska M, Norkowska M, Kamysz W, Myszka H, Liberek B.. (2019) N-Aminoacyl and N-hydroxyacyl derivatives of diosgenyl 2-amino-2-deoxy-β-d-glucopyranoside: Synthesis, antimicrobial and hemolytic activities., 27 (20): [PMID:31153729] [10.1016/j.bmc.2019.05.036] |
Source(1):